Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Outlook Therapeutics Inc (NQ: OTLK ) 7.280 +0.230 (+3.26%) Streaming Delayed Price Updated: 2:23 PM EDT, Aug 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 92,133 Open 7.040 Bid (Size) 7.280 (3) Ask (Size) 7.300 (4) Prev. Close 7.050 Today's Range 6.960 - 7.300 52wk Range 4.004 - 34.00 Shares Outstanding 23,405,637 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices July 11, 2024 Beaten-down stocks offer value to investors, but not all are worth buying. This is a look at three biopharma at long-term lows with catalysts for higher prices. Via MarketBeat 3 Undervalued Gems Set to Soar 1,000% by 2026 June 25, 2024 Discover the fundamentals behind three undervalued stocks to buy in the oil and gas, advertising, and biotechnology industries. Via InvestorPlace Performance YTD -7.40% -7.40% 1 Month -7.38% -7.38% 3 Month -14.35% -14.35% 6 Month +2.13% +2.13% 1 Year -77.80% -77.80% More News Read More MarketBeat Week in Review – 6/17 - 6/21 June 22, 2024 Via MarketBeat Topics Economy Stocks Exposures Interest Rates US Equities Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside June 19, 2024 Via MarketBeat OTLK Stock Earnings: Outlook Therapeutics Misses EPS for Q2 2024 May 15, 2024 Via InvestorPlace Biotech on a Budget: 7 Stocks Under $10 With Huge Potential April 15, 2024 Via InvestorPlace Insiders Buying Outlook Therapeutics And 2 Other Stocks April 01, 2024 Via Benzinga Gold Moves Lower; Lululemon Shares Plummet March 22, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session March 22, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session March 22, 2024 Via Benzinga Dow Dips 200 Points; Nike Shares Fall After Q3 Results March 22, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Higher On Friday? March 22, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session March 22, 2024 Via Benzinga Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying March 12, 2024 Via Benzinga Topics Stocks Exposures US Equities 7 of the Best Speculative Stocks You Can Snag for Less Than $1 March 06, 2024 Via InvestorPlace 7 Biotech Penny Stocks on the Verge of Clinical Trial Victory February 25, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session February 22, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session January 23, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session January 23, 2024 Via Benzinga OTLK DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK January 01, 2024 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Product Safety OTLK DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action – OTLK January 01, 2024 From The Rosen Law Firm, P.A. Via Business Wire OTLK IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK December 31, 2023 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Product Safety OTLK DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OTLK December 31, 2023 From The Rosen Law Firm PA Via GlobeNewswire OTLK DEADLINE ALERT: ROSEN, A LEADING AND RANKED FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK December 30, 2023 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Product Safety OUTLOOK DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Outlook Therapeutics, Inc. and Encourages Investors to Contact the Firm December 29, 2023 From Bragar Eagel & Squire, P.C. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
